| Date Filed | Type | Description |
| 08/11/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/16/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/28/2023 |
X-17A-5
| Form X-17A-5 - FOCUS Report: |
| 02/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 01/24/2023 |
4
| SUSQUEHANNA SECURITIES, LLC (10% Owner) has filed a Form 4 on Tailwind Acquisition Corp.|
Txns:
| Exercised (in-or-at-the-money) 3,725 options to buy
@ $10, valued at
$37.3k
Unknown transaction of 10 options to buy
@ $12.5, valued at
$125
Exercised (in-or-at-the-money) 3 options to buy
@ $7.5, valued at
$22.5
Unknown transaction of 44 options to buy
@ $7.5, valued at
$330
Exercised (in-or-at-the-money) 202 options to buy
@ $12.5, valued at
$2.5k
|
|
| 11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
3
| SUSQUEHANNA SECURITIES, LLC (10% Owner) has filed a Form 3 on IG Acquisition Corp. |
| 09/20/2022 |
4
| SUSQUEHANNA SECURITIES, LLC (10% Owner) has filed a Form 4 on Tailwind Acquisition Corp.|
Txns:
| Exercised (in-or-at-the-money) 85 options to buy
@ $7.5, valued at
$637.5
Unknown transaction of 5 options to buy
@ $10, valued at
$50
Exercised (in-or-at-the-money) 16 options to buy
@ $10, valued at
$160
Unknown transaction of 15 options to buy
@ $10, valued at
$150 |
|
| 09/19/2022 |
3
| SUSQUEHANNA SECURITIES, LLC (10% Owner) has filed a Form 3 on Tailwind Acquisition Corp. |
| 08/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/16/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/25/2022 |
X-17A-5
| Form X-17A-5 - FOCUS Report: |
| 02/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/15/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/11/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/17/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/26/2021 |
X-17A-5
| Form X-17A-5 - FOCUS Report: |
| 02/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/16/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/14/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/15/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/25/2020 |
X-17A-5
| Form X-17A-5 - FOCUS Report: |
| 02/14/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 01/30/2020 |
4
| G1 EXECUTION SERVICES, LLC (10% Owner) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed of 10,917 shares
@ $6.3, valued at
$68.8k
Disposed of 14,115,498 shares
@ $6.3, valued at
$88.9M
|
|
| 01/30/2020 |
3
| G1 EXECUTION SERVICES, LLC (10% Owner) has filed a Form 3 on ACHILLION PHARMACEUTICALS INC |
| 11/14/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/14/2019 |
13F-NT/A
| Form 13F-NT/A - Quarterly report filed by institutional managers, Notice: [Amend] |
| 11/14/2019 |
13F-NT/A
| Form 13F-NT/A - Quarterly report filed by institutional managers, Notice: [Amend] |
| 08/16/2019 |
13F-NT/A
| Form 13F-NT/A - Quarterly report filed by institutional managers, Notice: [Amend] |
| 08/14/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/15/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/25/2019 |
X-17A-5
| Form X-17A-5 - FOCUS Report: |
| 02/14/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
|